Suppr超能文献

多因素干预对哮喘合并超重儿童的影响(Mikado):一项随机对照试验的研究设计。

Multifactorial intervention for children with asthma and overweight (Mikado): study design of a randomised controlled trial.

机构信息

Department of Paediatric Respiratory Medicine, School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre (MUMC), P, Debyelaan 25, P,O, Box 5800, Maastricht, AZ, 6202, The Netherlands.

出版信息

BMC Public Health. 2013 May 21;13:494. doi: 10.1186/1471-2458-13-494.

Abstract

BACKGROUND

In children, the prevalence's of both obesity and asthma are disconcertingly high. Asthmatic children with obesity are characterised by less asthma control and a high need for asthma medication. As the obese asthmatic child is becoming more common in the clinical setting and the disease burden of the asthma-obesity phenotype is high, there is an increasing need for effective treatment in these children. In adults, weight reduction resulted in improved lung function, better asthma control and less need for asthma medication. In children this is hardly studied. The Mikado study aims to evaluate the effectiveness of a long term multifactorial weight reduction intervention, on asthma characteristics in children with asthma and a high body weight.

METHODS/DESIGN: The Mikado study is a two-armed, randomised controlled trial. In total, 104 participants will be recruited via online questionnaires, pulmonary paediatricians, the youth department of the Municipal Health Services and cohorts of existing studies. All participants will be aged 6-16 years, will have current asthma, a Body Mass Index in the overweight or obesity range, and no serious comorbidities (such as diabetes, heart diseases). Participants in the intervention arm will receive a multifactorial intervention of 18 months consisting of sessions concerning sports, parental involvement, individual counselling and lifestyle advices including dietary advices and cognitive behavioural therapy. The control group will receive usual care. The primary outcome variables will include Forced Expiratory Volume in one second and Body Mass Index - Standard Deviation Score. Secondary outcomes will include other lung function parameters (including dynamic and static lung function parameters), asthma control, asthma-specific quality of life, use of asthma medication and markers of systemic inflammation and airway inflammation.

DISCUSSION

In this randomised controlled trial we will study the potential of a multifactorial weight reduction intervention to improve asthma-related outcome measures in asthmatic children with overweight. Moreover, it will provide information about the underlying mechanisms in the relationship between asthma and a high body weight in children. These findings can contribute to optimal management programs and better clinical guidelines for children with asthma and overweight.

TRIAL REGISTRATION

Clinicaltrial.gov NCT00998413.

摘要

背景

在儿童中,肥胖和哮喘的患病率令人担忧地高。肥胖哮喘儿童的哮喘控制较差,需要大量哮喘药物。由于肥胖哮喘儿童在临床环境中越来越常见,且哮喘-肥胖表型的疾病负担较高,因此需要对这些儿童进行有效的治疗。在成年人中,减肥可改善肺功能,更好地控制哮喘,并减少对哮喘药物的需求。在儿童中,这方面的研究很少。Mikado 研究旨在评估长期多因素减肥干预对超重肥胖哮喘儿童哮喘特征的有效性。

方法/设计:Mikado 研究是一项双臂、随机对照试验。总共将通过在线问卷、儿科肺科医生、市卫生服务青年部门和现有研究队列招募 104 名参与者。所有参与者年龄为 6-16 岁,目前患有哮喘,体重指数处于超重或肥胖范围,且无严重合并症(如糖尿病、心脏病)。干预组的参与者将接受为期 18 个月的多因素干预,包括运动、父母参与、个体咨询和生活方式建议,包括饮食建议和认知行为疗法。对照组将接受常规护理。主要结局变量将包括 1 秒用力呼气量和体重指数标准差评分。次要结局将包括其他肺功能参数(包括动态和静态肺功能参数)、哮喘控制、哮喘特异性生活质量、哮喘药物使用以及全身炎症和气道炎症标志物。

讨论

在这项随机对照试验中,我们将研究多因素减肥干预改善超重哮喘儿童哮喘相关结局指标的潜力。此外,它将提供关于儿童哮喘和高体重之间关系的潜在机制的信息。这些发现可以为超重哮喘儿童的最佳管理方案和更好的临床指南提供信息。

试验注册

Clinicaltrial.gov NCT00998413。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7300/3682864/001ddbd93567/1471-2458-13-494-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验